Thoracic medical oncologist · UCSF Medical Center · United States (US) · Oncology
Data minimisation
Cadence target for Tier 2: 2 per year (assumption)
2 of 1 expected engagements
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 08 Aug 2026 | Investigator meeting | Virtual | Rachel Adeyemi | Vantrexa | Brain-metastasis subgroup data | 1 | MI request | Reviewed | ENG-0090 |
| 03 May 2026 | Scientific exchange | Phone | Rachel Adeyemi | Vantrexa | Sequencing after progressionElderly / ECOG 2 patients | 1 | — | Reviewed | ENG-0046 |
| 03 Feb 2026 | Scientific exchange | In person | Rachel Adeyemi | Vantrexa | PD-L1 testing turnaroundComparator checkpoint monotherapy+1 | 1 | — | Reviewed | ENG-0085 |
08 Aug 2026
Brain-metastasis subgroup data
03 May 2026
Sequencing after progression, Elderly / ECOG 2 patients
03 Feb 2026
PD-L1 testing turnaround, Comparator checkpoint monotherapy, Duration of response
UCSF Medical Center
Allergist
Allergist